You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Aurobindo Pharma Usa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA USA, and what generic and branded alternatives to AUROBINDO PHARMA USA drugs are available?

AUROBINDO PHARMA USA has sixty-five approved drugs.

There are two tentative approvals on AUROBINDO PHARMA USA drugs.

Summary for Aurobindo Pharma Usa

US Patents:	0
Tradenames:	56
Ingredients:	55
NDAs:	65
Patent Litigation for Aurobindo Pharma Usa:	See patent lawsuits for Aurobindo Pharma Usa
PTAB Cases with Aurobindo Pharma Usa as petitioner:	See PTAB cases with Aurobindo Pharma Usa as petitioner

Drugs and US Patents for Aurobindo Pharma Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Usa	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	CAPSULE;ORAL	040319-001	Sep 7, 1999	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	AMANTADINE HYDROCHLORIDE	amantadine hydrochloride	SYRUP;ORAL	074170-001	Oct 28, 1994	AA	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	CAPTOPRIL	captopril	TABLET;ORAL	074434-003	Feb 13, 1996		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	CAPTOPRIL	captopril	TABLET;ORAL	074434-001	Feb 13, 1996		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	200475-002	Dec 19, 2011		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aurobindo Pharma Usa

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,105,783	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE-25	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-003	May 13, 1988	4,444,769	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,444,769	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.